These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

548 related items for PubMed ID: 17961517

  • 1. Genomic analysis of response to traumatic brain injury in a mouse model of Alzheimer's disease (APPsw).
    Crawford FC, Wood M, Ferguson S, Mathura VS, Faza B, Wilson S, Fan T, O'Steen B, Ait-Ghezala G, Hayes R, Mullan MJ.
    Brain Res; 2007 Dec 14; 1185():45-58. PubMed ID: 17961517
    [Abstract] [Full Text] [Related]

  • 2. Traumatic brain injury in young, amyloid-beta peptide overexpressing transgenic mice induces marked ipsilateral hippocampal atrophy and diminished Abeta deposition during aging.
    Nakagawa Y, Nakamura M, McIntosh TK, Rodriguez A, Berlin JA, Smith DH, Saatman KE, Raghupathi R, Clemens J, Saido TC, Schmidt ML, Lee VM, Trojanowski JQ.
    J Comp Neurol; 1999 Aug 30; 411(3):390-8. PubMed ID: 10413774
    [Abstract] [Full Text] [Related]

  • 3. Caspase inhibition therapy abolishes brain trauma-induced increases in Abeta peptide: implications for clinical outcome.
    Abrahamson EE, Ikonomovic MD, Ciallella JR, Hope CE, Paljug WR, Isanski BA, Flood DG, Clark RS, DeKosky ST.
    Exp Neurol; 2006 Feb 30; 197(2):437-50. PubMed ID: 16300758
    [Abstract] [Full Text] [Related]

  • 4. Brain trauma in aged transgenic mice induces regression of established abeta deposits.
    Nakagawa Y, Reed L, Nakamura M, McIntosh TK, Smith DH, Saatman KE, Raghupathi R, Clemens J, Saido TC, Lee VM, Trojanowski JQ.
    Exp Neurol; 2000 May 30; 163(1):244-52. PubMed ID: 10785464
    [Abstract] [Full Text] [Related]

  • 5. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
    Mohmmad Abdul H, Sultana R, Keller JN, St Clair DK, Markesbery WR, Butterfield DA.
    J Neurochem; 2006 Mar 30; 96(5):1322-35. PubMed ID: 16478525
    [Abstract] [Full Text] [Related]

  • 6. Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury.
    Ikonomovic MD, Uryu K, Abrahamson EE, Ciallella JR, Trojanowski JQ, Lee VM, Clark RS, Marion DW, Wisniewski SR, DeKosky ST.
    Exp Neurol; 2004 Nov 30; 190(1):192-203. PubMed ID: 15473992
    [Abstract] [Full Text] [Related]

  • 7. Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease.
    Wu ZL, Ciallella JR, Flood DG, O'Kane TM, Bozyczko-Coyne D, Savage MJ.
    Neurobiol Aging; 2006 Mar 30; 27(3):377-86. PubMed ID: 15927307
    [Abstract] [Full Text] [Related]

  • 8. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease.
    Pihlaja R, Koistinaho J, Malm T, Sikkilä H, Vainio S, Koistinaho M.
    Glia; 2008 Jan 15; 56(2):154-63. PubMed ID: 18004725
    [Abstract] [Full Text] [Related]

  • 9. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
    Yao J, Petanceska SS, Montine TJ, Holtzman DM, Schmidt SD, Parker CA, Callahan MJ, Lipinski WJ, Bisgaier CL, Turner BA, Nixon RA, Martins RN, Ouimet C, Smith JD, Davies P, Laska E, Ehrlich ME, Walker LC, Mathews PM, Gandy S.
    J Neurochem; 2004 Aug 15; 90(4):1011-8. PubMed ID: 15287908
    [Abstract] [Full Text] [Related]

  • 10. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model.
    Holtzman DM, Fagan AM, Mackey B, Tenkova T, Sartorius L, Paul SM, Bales K, Ashe KH, Irizarry MC, Hyman BT.
    Ann Neurol; 2000 Jun 15; 47(6):739-47. PubMed ID: 10852539
    [Abstract] [Full Text] [Related]

  • 11. Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation.
    Koistinaho M, Kettunen MI, Goldsteins G, Keinänen R, Salminen A, Ort M, Bures J, Liu D, Kauppinen RA, Higgins LS, Koistinaho J.
    Proc Natl Acad Sci U S A; 2002 Feb 05; 99(3):1610-5. PubMed ID: 11818564
    [Abstract] [Full Text] [Related]

  • 12. Viral-induced inflammation is accompanied by beta-amyloid plaque reduction in brains of amyloid precursor protein transgenic Tg2576 mice.
    Stahl T, Reimers C, Johne R, Schliebs R, Seeger J.
    Eur J Neurosci; 2006 Oct 05; 24(7):1923-34. PubMed ID: 17067295
    [Abstract] [Full Text] [Related]

  • 13. Aberrant expressions of pathogenic phenotype in Alzheimer's diseased transgenic mice carrying NSE-controlled APPsw.
    Hwang DY, Cho JS, Lee SH, Chae KR, Lim HJ, Min SH, Seo SJ, Song YS, Song CW, Paik SG, Sheen YY, Kim YK.
    Exp Neurol; 2004 Mar 05; 186(1):20-32. PubMed ID: 14980807
    [Abstract] [Full Text] [Related]

  • 14. Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model.
    Refolo LM, Malester B, LaFrancois J, Bryant-Thomas T, Wang R, Tint GS, Sambamurti K, Duff K, Pappolla MA.
    Neurobiol Dis; 2000 Aug 05; 7(4):321-31. PubMed ID: 10964604
    [Abstract] [Full Text] [Related]

  • 15. Association of increased cortical soluble abeta42 levels with diffuse plaques after severe brain injury in humans.
    DeKosky ST, Abrahamson EE, Ciallella JR, Paljug WR, Wisniewski SR, Clark RS, Ikonomovic MD.
    Arch Neurol; 2007 Apr 05; 64(4):541-4. PubMed ID: 17420316
    [Abstract] [Full Text] [Related]

  • 16. Nitric oxide in the cerebral cortex of amyloid-precursor protein (SW) Tg2576 transgenic mice.
    Rodrigo J, Fernández-Vizarra P, Castro-Blanco S, Bentura ML, Nieto M, Gómez-Isla T, Martínez-Murillo R, MartInez A, Serrano J, Fernández AP.
    Neuroscience; 2004 Apr 05; 128(1):73-89. PubMed ID: 15450355
    [Abstract] [Full Text] [Related]

  • 17. Selective vulnerability of different types of commissural neurons for amyloid beta-protein-induced neurodegeneration in APP23 mice correlates with dendritic tree morphology.
    Capetillo-Zarate E, Staufenbiel M, Abramowski D, Haass C, Escher A, Stadelmann C, Yamaguchi H, Wiestler OD, Thal DR.
    Brain; 2006 Nov 05; 129(Pt 11):2992-3005. PubMed ID: 16844716
    [Abstract] [Full Text] [Related]

  • 18. Occurrence and co-localization of amyloid beta-protein and apolipoprotein E in perivascular drainage channels of wild-type and APP-transgenic mice.
    Thal DR, Larionov S, Abramowski D, Wiederhold KH, Van Dooren T, Yamaguchi H, Haass C, Van Leuven F, Staufenbiel M, Capetillo-Zarate E.
    Neurobiol Aging; 2007 Aug 05; 28(8):1221-30. PubMed ID: 16815595
    [Abstract] [Full Text] [Related]

  • 19. Nasal administration of amyloid-beta peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease.
    Weiner HL, Lemere CA, Maron R, Spooner ET, Grenfell TJ, Mori C, Issazadeh S, Hancock WW, Selkoe DJ.
    Ann Neurol; 2000 Oct 05; 48(4):567-79. PubMed ID: 11026440
    [Abstract] [Full Text] [Related]

  • 20. Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice.
    Lazarov O, Robinson J, Tang YP, Hairston IS, Korade-Mirnics Z, Lee VM, Hersh LB, Sapolsky RM, Mirnics K, Sisodia SS.
    Cell; 2005 Mar 11; 120(5):701-13. PubMed ID: 15766532
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.